| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |